Long-term reduction of C-reactive protein concentration by regular LDL apheresis.
作者： Carsten Otto , H.Christian Geiss , Klaus Empen , Klaus G. Parhofer
DOI: 10.1016/J.ATHEROSCLEROSIS.2004.01.017
关键词:
摘要: … mg/l, range: 0.16–4.33 mg/l) compared to before the first apheresis (median: 0.85 mg/l, range: … lower before a current apheresis compared to before the initial apheresis while fibrinogen …
elsevier.com
sci-hub.se 参考文章(21)
D. SEIDEL, V. W. ARMSTRONG, P. SCHUFF-WERNER, The HELP‐LDL‐apheresis multicentre study, an angiographically assessed trial on the role of LDL‐apheresis in the secondary prevention of coronary heart disease European Journal of Clinical Investigation. ,vol. 21, pp. 375- 383 ,(1991) , 10.1111/J.1365-2362.1991.TB01384.X
Winston L Hutchinson, Wolfgang Koenig, Margit Fröhlich, Malte Sund, Gordon D O Lowe, Mark B Pepys, Immunoradiometric Assay of Circulating C-Reactive Protein: Age-related Values in the Adult General Population Clinical Chemistry. ,vol. 46, pp. 934- 938 ,(2000) , 10.1093/CLINCHEM/46.7.934
P. SCHUFF-WERNER, H. GOHLKE, U. BARTMANN, G. BAGGIO, M. C. CORTI, A. DINSENBACHER, T. EISENHAUER, P. GRÜTZMACHER, C. KELLER, U. KETTNER, W. KLEOPHAS, W. KÖSTER, C. J. OLBRICHT, W. O. RICHTER, D. SEIDEL, THE HELP-STUDY GROUP, The HELP-LDL-apheresis multicentre study, an angiographically assessed trial on the role of LDL-apheresis in the secondary prevention of coronary heart disease. II. Final evaluation of the effect of regular treatment on LDL-cholesterol plasma concentrations and the course of coronary heart disease* European Journal of Clinical Investigation. ,vol. 24, pp. 724- 732 ,(1994) , 10.1111/J.1365-2362.1994.TB01068.X
C. Otto, P. Schwandt, C-reactive protein concentration is reduced by different types of LDL apheresis Atherosclerosis Supplements. ,vol. 2, pp. 81- 82 ,(2001) , 10.1016/S1567-5688(01)80193-8
Hiroshi Mabuchi, Junji Koizumi, Masami Shimizu, Kouji Kajinami, Susumu Miyamoto, Kousei Ueda, Tadayoshi Takegoshi, Long-term efficacy of low-density lipoprotein apheresis on coronary heart disease in familial hypercholesterolemia American Journal of Cardiology. ,vol. 82, pp. 1489- 1495 ,(1998) , 10.1016/S0002-9149(98)00692-4
Abraham A. Kroon, Wim R.M. Aengevaeren, Tjeerd van der Werf, Gerard J.H. Uijen, Johan H.C. Reiber, Albert V.G. Bruschke, Anton F.H. Stalenhoef, LDL-Apheresis Atherosclerosis Regression Study (LAARS) Effect of Aggressive Versus Conventional Lipid Lowering Treatment on Coronary Atherosclerosis Circulation. ,vol. 93, pp. 1826- 1835 ,(1996) , 10.1161/01.CIR.93.10.1826
Jian-Jun Li, Ming-Zhe Chen, Xin Chen, Chun-Hong Fang, Rapid effects of simvastatin on lipid profile and C-reactive protein in patients with hypercholesterolemia. Clinical Cardiology. ,vol. 26, pp. 472- 476 ,(2003) , 10.1002/CLC.4960261008
Shunichi Kojima, Mikio Shida, Hiroyuki Yokoyama, Changes in C‐reactive Protein Plasma Levels During Low‐density Lipoprotein Apheresis Therapeutic Apheresis and Dialysis. ,vol. 7, pp. 431- 434 ,(2003) , 10.1046/J.1526-0968.2003.00080.X
Eberhard Wieland, Volker Schettler, Victor William Armstrong, Highly effective reduction of C-reactive protein in patients with coronary heart disease by extracorporeal low density lipoprotein apheresis. Atherosclerosis. ,vol. 162, pp. 187- 191 ,(2002) , 10.1016/S0021-9150(01)00698-0
John Danesh, Rory Collins, Paul Appleby, Richard Peto, Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. JAMA. ,vol. 279, pp. 1477- 1482 ,(1998) , 10.1001/JAMA.279.18.1477